These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 7981496)
1. The selective anticancer activity of the endogenous inhibitor of calcium-activated neutral proteinase. A histological, cytological and chemosensitivity study. Logothetou-Rella H Histol Histopathol; 1994 Jul; 9(3):485-93. PubMed ID: 7981496 [TBL] [Abstract][Full Text] [Related]
2. The inhibitor of calcium activated neutral proteinase is an anti-meiotic agent. The spermicidal and anti-viral action. Logothetou-Rella H Histol Histopathol; 1995 Apr; 10(2):271-82. PubMed ID: 7599427 [TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycan-sac formation in vitro. Interactions between normal and malignant cells. Logothetou-Rella H Histol Histopathol; 1994 Apr; 9(2):243-9. PubMed ID: 8075481 [TBL] [Abstract][Full Text] [Related]
4. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Frankel A; Man S; Elliott P; Adams J; Kerbel RS Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766 [TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
6. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activity. Hirabayashi K; Yano J; Inoue T; Yamaguchi T; Tanigawara K; Smyth GE; Ishiyama K; Ohgi T; Kimura K; Irimura T Cancer Res; 1999 Sep; 59(17):4325-33. PubMed ID: 10485480 [TBL] [Abstract][Full Text] [Related]
8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
9. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
10. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo. Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte interactions with the extracellular matrix of malignant cells in vitro: a morphological and immunocytochemical study. Logothetou-Rella H Histol Histopathol; 1993 Oct; 8(4):739-50. PubMed ID: 7508305 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of human lymphocytes into nuclear vlimata by meiosis. The cytotoxic effect of calcium-activated neutral proteinase inhibitor. Logothetou-Rella H Histol Histopathol; 1994 Jul; 9(3):469-84. PubMed ID: 7981495 [TBL] [Abstract][Full Text] [Related]
13. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo. Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317 [TBL] [Abstract][Full Text] [Related]
14. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936 [TBL] [Abstract][Full Text] [Related]
15. [Preliminary study on skeletal muscle derived tumor suppressor]. Luo C; Jiang Y; Liu Y Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):17-20. PubMed ID: 11783061 [TBL] [Abstract][Full Text] [Related]
17. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas. Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967 [TBL] [Abstract][Full Text] [Related]
18. [Bestrabacil: a possible target-oriented anticancer agent]. Ohsawa N; Yamazaki Z; Wagatsuma T; Isurugi K Gan To Kagaku Ryoho; 1984 Oct; 11(10):2115-24. PubMed ID: 6548354 [TBL] [Abstract][Full Text] [Related]
19. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy. Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767 [TBL] [Abstract][Full Text] [Related]
20. Meiosis in hematological malignancies. In situ cytogenetic morphology. Logothetou-Rella H Histol Histopathol; 1996 Oct; 11(4):943-63. PubMed ID: 8930639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]